Patents by Inventor Paul A. Olivier

Paul A. Olivier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240135969
    Abstract: Various apparatuses, systems, methods, and media are disclosed for heat-assisted magnetic recording (HAMR) that, in some examples, provide a HAMR medium with two soft underlayers (SULs) on opposing sides of a single heatsink layer. For example, a magnetic recording medium is provided that includes a lower SUL on a substrate. The lower SUL is configured and positioned within the medium to provide a first return path for magnetic flux from a magnetic recording head during a write operation. The medium also includes a heatsink layer on the lower SUL and an upper SUL on the heatsink layer. The upper SUL is configured and positioned within the medium to provide a second return path for magnetic flux from the magnetic recording head. A magnetic recording layer is provided on the upper SUL to store information during the write operation. Additional layers or films may be provided as well.
    Type: Application
    Filed: July 24, 2023
    Publication date: April 25, 2024
    Inventors: Asif Bashir, Pierre-Olivier Jubert, Antony Ajan, Paul Christopher Dorsey
  • Publication number: 20230331824
    Abstract: Single-domain antibodies that bind the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) spike protein are disclosed. The single-domain antibodies include binding domains that bind epitopes of the Spike ectodomain inside and outside the receptor binding domain. The single-domain antibodies can be used for multiple purposes including in the research, diagnosis, and prophylactic or therapeutic treatment of COVID-19.
    Type: Application
    Filed: August 20, 2021
    Publication date: October 19, 2023
    Applicants: The Rockefeller University, Seattle Children's Hospital d/b/a Seattle Children's Research Institute, New York University
    Inventors: Brian T. Chait, Michael P. Rout, John Aitchison, Fred David Mast, Jean Paul Olivier, David Fenyo
  • Publication number: 20230047952
    Abstract: An assembly for a turbomachine extending along an axis includes a combustion chamber having, at its downstream end, a downstream flange having a radially extending part. The assembly further includes a distributor disposed downstream of the combustion chamber and having a platform from which at least one vane extends radially. The platform includes an upstream flange extending radially and delimiting, with the radial part of the downstream flange disposed opposite it. An annular space for the circulation of cooling air opens into the combustion chamber at its radially internal end and has, at its radially external end, means of sealing attached to the distributor.
    Type: Application
    Filed: January 20, 2021
    Publication date: February 16, 2023
    Applicant: SAFRAN AIRCRAFT ENGINES
    Inventors: Paul Olivier DANRE, Jean-Luc BACHA, Julie Laure Antoinette BUREL, Julien Michel TAMIZIER, Christophe Bernard TEXIER
  • Patent number: 10759312
    Abstract: A vehicle trim assembly comprises a foam bun, an electrically insulative top finish layer above the foam bun, a thermal gradient assembly under the finish trim layer, and a thermal enhancement layer between the thermal gradient assembly and the finish trim layer. The thermal gradient assembly is adapted to generate a thermal gradient when receiving an electric current and has an electrically conductive top layer, an electrically conductive bottom layer, and a semiconductor layer having first and second semiconductor regions between the top and bottom layers. The thermal enhancement layer has a thermal conductivity adapted to direct thermal energy transfer between the thermal gradient assembly and the finish trim layer.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: September 1, 2020
    Assignee: Lear Corporation
    Inventors: Ashford Allen Galbreath, Arjun Yetukuri, Paul Olivier, Colin Andrew Paton-Phillips, David Gallagher
  • Publication number: 20190184869
    Abstract: A vehicle trim assembly comprises a foam bun, an electrically insulative top finish layer above the foam bun, a thermal gradient assembly under the finish trim layer, and a thermal enhancement layer between the thermal gradient assembly and the finish trim layer. The thermal gradient assembly is adapted to generate a thermal gradient when receiving an electric current and has an electrically conductive top layer, an electrically conductive bottom layer, and a semiconductor layer having first and second semiconductor regions between the top and bottom layers. The thermal enhancement layer has a thermal conductivity adapted to direct thermal energy transfer between the thermal gradient assembly and the finish trim layer.
    Type: Application
    Filed: December 20, 2017
    Publication date: June 20, 2019
    Applicant: Lear Corporation
    Inventors: Ashford Allen Galbreath, Arjun Yetukuri, Paul Olivier, Colin Andrew Paton-Phillips, David Gallagher
  • Patent number: 10070601
    Abstract: The invention provides a plant cell, part, tissue culture or whole plant comprising at least one disrupted KRP gene of the present invention. The present invention also provides methods of increasing weight, size, and/or number of one or more organs, and/or yield of a plant by utilizing the disrupted KRP genes of the present invention. Furthermore, methods of breeding plants to produce new plants having increased weight, size, and/or number of one or more organs, and/or yield are provided. The present invention provides isolated Kinase inhibitor Protein (KIP) Related Protein (KRP) polynucleotide sequences and isolated KRP polypeptide sequences and methods of their use. Exemplary plants include wheat, rice and soy bean.
    Type: Grant
    Filed: November 30, 2016
    Date of Patent: September 11, 2018
    Assignee: Targeted Growth, Inc.
    Inventors: Jean Paul Olivier, Dayna L. Loeffler
  • Publication number: 20170275640
    Abstract: Disclosed are mutant CDK inhibitor (CKI) polypeptides having dominant negative antagonist activity against wild-type CKI proteins, as well as related compositions, including nucleic acids and vectors encoding the mutant CKI polypeptides and transformed host cells and transgenic plants comprising such nucleic acids and vectors. Also disclosed are related methods for using the mutant proteins to modulate cell division in cells, particularly plant cells.
    Type: Application
    Filed: March 23, 2017
    Publication date: September 28, 2017
    Applicant: Targeted Growth, Inc.
    Inventors: Paul OLIVIER, Jay DEROCHER, James ROBERTS
  • Patent number: 9745596
    Abstract: The invention provides a wheat cell, part, tissue culture or whole plant comprising at least one disrupted KRP gene of the present invention. The present invention also provides methods of increasing weight, size, and/or number of one or more organs, and/or yield of a wheat plant by utilizing the disrupted KRP genes of the present invention. Furthermore, methods of breeding wheat plants to produce new wheat plants having increased weight, size, and/or number of one or more organs, and/or yield are provided. The present invention provides isolated Kinase Inhibitor Protein (KIP) Related Protein (KRP) polynucleotide sequences and isolated KRP polypeptide sequences and methods of their use.
    Type: Grant
    Filed: May 18, 2015
    Date of Patent: August 29, 2017
    Assignees: Targeted Growth, Inc., The Regents of the University of California
    Inventors: Jean Paul Olivier, Tom Todaro, Jorge Dubcovsky, Wenjun Zhang
  • Publication number: 20170183680
    Abstract: The present invention provides expression vectors comprising polynucleotides encoding mutant Zea mays KRP dominant negative proteins, and methods of using the same. In addition, transgenic plants expressing said KRP dominant negative proteins are provided. Furthermore, methods of increasing average seed weight, seed size, seed number and/or yield of a plant by using said KRP dominant negative proteins are provided.
    Type: Application
    Filed: March 2, 2017
    Publication date: June 29, 2017
    Applicant: Targeted Growth, Inc.
    Inventors: Jean Paul Olivier, James Michael ROBERTS
  • Publication number: 20170142919
    Abstract: The invention provides a plant cell, part, tissue culture or whole plant comprising at least one disrupted KRP gene of the present invention. The present invention also provides methods of increasing weight, size, and/or number of one or more organs, and/or yield of a plant by utilizing the disrupted KRP genes of the present invention. Furthermore, methods of breeding plants to produce new plants having increased weight, size, and/or number of one or more organs, and/or yield are provided. The present invention provides isolated Kinase inhibitor Protein (KIP) Related Protein (KRP) polynucleotide sequences and isolated KRP polypeptide sequences and methods of their use. Exemplary plants include wheat, rice and soy bean.
    Type: Application
    Filed: November 30, 2016
    Publication date: May 25, 2017
    Applicant: Targeted Growth, Inc.
    Inventors: Jean Paul OLIVIER, Dayna L. LOEFFLER
  • Patent number: 9637754
    Abstract: Disclosed are mutant CDK inhibitor (CKI) polypeptides having dominant negative antagonist activity against wild-type CKI proteins, as well as related compositions, including nucleic acids and vectors encoding the mutant CKI polypeptides and transformed host cells and transgenic plants comprising such nucleic acids and vectors. Also disclosed are related methods for using the mutant proteins to modulate cell division in cells, particularly plant cells.
    Type: Grant
    Filed: April 15, 2014
    Date of Patent: May 2, 2017
    Assignee: Targeted Growth, Inc.
    Inventors: Paul Olivier, Jay Derocher, James Roberts
  • Patent number: 9556448
    Abstract: The invention provides a plant cell, part, tissue culture or whole plant comprising at least one disrupted KRP gene of the present invention. The present invention also provides methods of increasing weight, size, and/or number of one or more organs, and/or yield of a plant by utilizing the disrupted KRP genes of the present invention. Furthermore, methods of breeding plants to produce new plants having increased weight, size, and/or number of one or more organs, and/or yield are provided. The present invention provides isolated Kinase Inhibitor Protein (KIP) Related Protein (KRP) polynucleotide sequences and isolated KRP polypeptide sequences and methods of their use. Exemplary plants include wheat, rice and soybean.
    Type: Grant
    Filed: April 11, 2012
    Date of Patent: January 31, 2017
    Assignee: Targeted Growth, Inc.
    Inventors: Jean Paul Olivier, Dayna L. Loeffler
  • Publication number: 20160002656
    Abstract: The invention provides a wheat cell, part, tissue culture or whole plant comprising at least one disrupted KRP gene of the present invention. The present invention also provides methods of increasing weight, size, and/or number of one or more organs, and/or yield of a wheat plant by utilizing the disrupted KRP genes of the present invention. Furthermore, methods of breeding wheat plants to produce new wheat plants having increased weight, size, and/or number of one or more organs, and/or yield are provided. The present invention provides isolated Kinase Inhibitor Protein (KIP) Related Protein (KRP) polynucleotide sequences and isolated KRP polypeptide sequences and methods of their use.
    Type: Application
    Filed: May 18, 2015
    Publication date: January 7, 2016
    Inventors: Jean Paul OLIVIER, Tom TODARO, Jorge DUBCOVSKY, Wenjun ZHANG
  • Patent number: 9062323
    Abstract: The invention provides a wheat cell, part, tissue culture or whole plant comprising at least one disrupted KRP gene of the present invention. The present invention also provides methods of increasing weight, size, and/or number of one or more organs, and/or yield of a wheat plant by utilizing the disrupted KRP genes of the present invention. Furthermore, methods of breeding wheat plants to produce new wheat plants having increased weight, size, and/or number of one or more organs, and/or yield are provided. The present invention provides isolated Kinase Inhibitor Protein (KIP) Related Protein (KRP) polynucleotide sequences and isolated KRP polypeptide sequences and methods of their use.
    Type: Grant
    Filed: April 11, 2012
    Date of Patent: June 23, 2015
    Assignees: The Regents of the University of California, Targeted Growth, Inc.
    Inventors: Jean Paul Olivier, Tom Todaro, Jorge Dubcovsky, Wenjun Zhang
  • Publication number: 20140331362
    Abstract: Disclosed are mutant CDK inhibitor (CKI) polypeptides having dominant negative antagonist activity against wild-type CKI proteins, as well as related compositions, including nucleic acids and vectors encoding the mutant CKI polypeptides and transformed host cells and transgenic plants comprising such nucleic acids and vectors. Also disclosed are related methods for using the mutant proteins to modulate cell division in cells, particularly plant cells.
    Type: Application
    Filed: April 15, 2014
    Publication date: November 6, 2014
    Applicant: TARGETED GROWTH, INC.
    Inventors: Paul OLIVIER, Jay DEROCHER, James Roberts
  • Publication number: 20140215653
    Abstract: The invention provides early embryo and early endosperm specific or preferred promoters, which are capable of driving and/or regulating the expression of an operably linked nucleic acid in a maize plant during early development of embryo and/or endosperm, and methods of isolating them. The promoters are derived from Zea mays or other plant species. The invention also provides compositions comprising one or more said promoters and methods of using the same.
    Type: Application
    Filed: October 23, 2013
    Publication date: July 31, 2014
    Applicant: TARGETED GROWTH, INC.
    Inventors: Jean Paul OLIVIER, James Michael Roberts, Fred Cross, Carolyn Hutcheon, Asha Palta
  • Patent number: 8742205
    Abstract: Disclosed are mutant CDK inhibitor (CKI) polypeptides having dominant negative antagonist activity against wild-type CKI proteins, as well as related compositions, including nucleic acids and vectors encoding the mutant CKI polypeptides and transformed host cells and transgenic plants comprising such nucleic acids and vectors. Also disclosed are related methods for using the mutant proteins to modulate cell division in cells, particularly plant cells.
    Type: Grant
    Filed: July 28, 2006
    Date of Patent: June 3, 2014
    Assignee: Targeted Growth, Inc.
    Inventors: Paul Olivier, Jay DeRocher, James M. Roberts
  • Publication number: 20140143900
    Abstract: The invention provides a plant cell, part, tissue culture or whole plant comprising at least one disrupted KRP gene of the present invention. The present invention also provides methods of increasing weight, size, and/or number of one or more organs, and/or yield of a plant by utilizing the disrupted KRP genes of the present invention. Furthermore, methods of breeding plants to produce new plants having increased weight, size, and/or number of one or more organs, and/or yield are provided. The present invention provides isolated Kinase Inhibitor Protein (KIP) Related Protein (KRP) polynucleotide sequences and isolated KRP polypeptide sequences and methods of their use. Exemplary plants include wheat, rice and soybean.
    Type: Application
    Filed: April 11, 2012
    Publication date: May 22, 2014
    Applicant: Targeted Growth, Inc.
    Inventors: Jean Paul Olivier, Dayna L. Loeffler
  • Publication number: 20140068817
    Abstract: The present invention provides expression vectors comprising polynucleotides encoding chimeric sucrose isomerases, and methods of using the same. In addition, transgenic plants expressing said chimeric sucrose isomerases are provided. Furthermore, methods of increasing average seed weight, seed number and/or seed size of a plant by using said chimeric sucrose isomerases are provided.
    Type: Application
    Filed: March 5, 2012
    Publication date: March 6, 2014
    Applicant: Targeted Growth, Inc.
    Inventors: Stefan Dittmar, George Singletary, Asha Palta, Barry Stoddard, Paul Olivier
  • Publication number: 20130005556
    Abstract: The present invention relates to a device and a method for placing immiscible fluid phases in contact with each other by means of centrifugal force, in particular in order to extract compounds from one of said phases by another phase. Said device comprises at least one contacting unit (3*) which is capable of being rotated about an axis (X?X) and which includes a plurality of cells (210, A, D) intended to be passed through consecutively by said phases, in a given flow direction, each cell being provided with two inlet/outlet channels (214 and 215) which fluidly connect the cells together in pairs and which lead into each cell, respectively, via two inlet/outlet openings, which are proximal (214a) and distal (215a) relative to the said axis, respectively.
    Type: Application
    Filed: November 26, 2010
    Publication date: January 3, 2013
    Applicants: UNIVERSITE DE NANTES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Alain Paul Olivier Foucault, Jack Legrand, Luc Marchal, Charles Elie Pierre Agaise